IRIS
SCICALI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.887
EU - Europa 4.049
AS - Asia 3.034
SA - Sud America 536
AF - Africa 471
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.739
SG - Singapore 1.411
RU - Federazione Russa 1.241
IT - Italia 1.157
NL - Olanda 781
CN - Cina 725
BR - Brasile 440
VN - Vietnam 305
IE - Irlanda 241
CI - Costa d'Avorio 240
KR - Corea 165
FR - Francia 140
IN - India 140
GB - Regno Unito 99
CA - Canada 96
SN - Senegal 78
DE - Germania 75
NG - Nigeria 75
UA - Ucraina 61
SE - Svezia 56
FI - Finlandia 53
TR - Turchia 47
PL - Polonia 44
HK - Hong Kong 37
AR - Argentina 33
MX - Messico 33
BD - Bangladesh 32
JP - Giappone 28
BJ - Benin 20
PK - Pakistan 20
ES - Italia 19
ZA - Sudafrica 19
IQ - Iraq 18
CO - Colombia 14
MA - Marocco 14
UZ - Uzbekistan 14
LT - Lituania 13
CL - Cile 12
EC - Ecuador 12
AT - Austria 11
IR - Iran 11
KE - Kenya 11
ID - Indonesia 10
VE - Venezuela 10
AU - Australia 7
AZ - Azerbaigian 7
CH - Svizzera 7
GR - Grecia 7
HR - Croazia 7
LB - Libano 7
PA - Panama 7
PY - Paraguay 7
SA - Arabia Saudita 6
IL - Israele 5
JO - Giordania 5
NP - Nepal 5
PH - Filippine 5
TH - Thailandia 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
EG - Egitto 4
KZ - Kazakistan 4
PE - Perù 4
AL - Albania 3
BE - Belgio 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GD - Grenada 2
HN - Honduras 2
MT - Malta 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
CG - Congo 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
Totale 12.978
Salva come PNG Salva come JPEG
Città #
Dallas 937
Singapore 932
Santa Clara 723
Eygelshoven 676
Moscow 567
Chandler 434
Ashburn 315
San Jose 310
Chicago 283
Hefei 260
Abidjan 240
Dublin 238
Catania 223
Seoul 165
Civitanova Marche 152
Los Angeles 131
Beijing 128
Boardman 123
Lauterbourg 102
Ho Chi Minh City 98
Rome 95
Amsterdam 89
Kochi 81
Council Bluffs 78
Dakar 78
New York 72
Cambridge 66
Lawrence 60
Hanoi 59
Andover 58
Jacksonville 56
Dong Ket 51
Lagos 42
São Paulo 42
Wilmington 42
Milan 41
Buffalo 36
Orem 36
Warsaw 36
Montreal 35
Des Moines 34
Hong Kong 32
Lappeenranta 32
Palermo 31
Toronto 31
Abuja 28
Nanjing 28
Tokyo 27
Bremen 24
Denver 24
Stockholm 23
Chennai 22
Houston 22
London 22
Rosolini 21
The Dalles 21
Brooklyn 20
Carrara 20
Cotonou 20
Padova 19
Belo Horizonte 18
Seattle 16
Atlanta 15
Johannesburg 15
Messina 15
Poplar 15
Manchester 14
Munich 14
Saint Petersburg 14
Columbus 13
Rio de Janeiro 13
San Francisco 13
Ankara 12
Menlo Park 12
Mumbai 12
Boston 11
Brasília 11
Istanbul 11
Mexico City 11
Nairobi 11
Shenyang 11
Turku 11
Bari 10
Enna 10
Gravina di Catania 10
Hebei 10
Helsinki 10
Da Nang 9
San Mateo 9
Tashkent 9
Tehran 9
Washington 9
Baghdad 8
Frankfurt am Main 8
Naples 8
Nuremberg 8
Ottawa 8
Phoenix 8
Querétaro 8
Reggio Emilia 8
Totale 9.138
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 555
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 552
Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study 351
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 261
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 194
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 180
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 174
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 172
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 163
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 161
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 151
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 150
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 146
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 146
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 145
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 145
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 144
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 143
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 141
Clinical and molecular biomarkers for diagnosis and staging of nafld 141
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 141
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 140
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 139
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 138
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 137
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 136
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 136
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 136
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 132
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 130
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 129
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 129
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 128
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 128
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 127
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 125
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 124
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 123
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 121
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 120
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 116
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 115
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 115
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 115
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 114
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 113
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 113
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 112
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 110
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 109
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 109
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 109
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 106
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 102
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 102
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 102
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 101
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 100
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency 100
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 100
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 99
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 99
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 98
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 98
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 98
Advancements in risk stratification and management strategies in primary cardiovascular prevention 96
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 96
Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes 93
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 93
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 93
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 93
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 92
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 92
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 92
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 91
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 91
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study 91
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 89
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 89
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease 89
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 88
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature 86
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare 85
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 85
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 84
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 84
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia 83
Corticosteroid replacement therapy in hepatoadrenal syndrome: case report with a review of the literature 83
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 83
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 81
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 80
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 80
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 79
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis. 79
Studio dell'effetto incretinivo e della funzione beta cellulare in soggetti con prediabete e diabete di neo diagnosi 77
Associations between Host Genetic Variants and Subgingival Microbiota in Patients with the Metabolic Syndrome 77
L'emoglobina glicosilata, meglio della curva da carico, permette l'identificazione di soggetti con prediabete ed elevato rischio cardiovascolare 76
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 75
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 75
Impairment of Regenerative and Metabolic Pathways in Intestinal Organoids From Patients With MASLD-Cirrhosis 72
Totale 12.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 37 31 62
2021/2022534 37 57 1 21 90 38 70 41 27 7 21 124
2022/20231.115 69 95 33 137 105 170 5 192 214 14 42 39
2023/2024798 37 118 50 27 45 165 52 89 10 27 104 74
2024/20252.943 70 400 138 261 554 390 134 77 145 226 337 211
2025/20267.270 384 447 1.126 523 967 2.137 729 131 414 412 0 0
Totale 13.220